GSR announced a $100 million investment and strategic partnership with MEI Pharma to serve as a treasury manager and advisor. This investment aims to institutionalize Litecoin as a treasury asset. GSR will collaborate with Litecoin creator Charlie Lee and the Litecoin Foundation, with Lee joining MEI's Board of Directors. This partnership marks a significant move towards aligning a public company's treasury strategy with Litecoin, showcasing institutional confidence in Litecoin's potential as a credible, resilient digital asset.
Litecoin has consistently delivered a stable, low-cost, and accessible network for over a decade, trusted by users and integrated across retail and payments.
This initiative represents the first time a public company is aligning its treasury strategy with Litecoin at an institutional level, reflecting rising institutional confidence in LTC's credibility.
Collection
[
|
...
]